146 related articles for article (PubMed ID: 38069034)
21. Upregulation of UBE2Q1 via gene copy number gain in hepatocellular carcinoma promotes cancer progression through β-catenin-EGFR-PI3K-Akt-mTOR signaling pathway.
Zhang B; Deng C; Wang L; Zhou F; Zhang S; Kang W; Zhan P; Chen J; Shen S; Guo H; Zhang M; Wang Y; Zhang F; Zhang W; Xiao J; Kong B; Friess H; Zhuge Y; Yan H; Zou X
Mol Carcinog; 2018 Feb; 57(2):201-215. PubMed ID: 29027712
[TBL] [Abstract][Full Text] [Related]
22. Phosphorylation of mTOR Ser2481 is a key target limiting the efficacy of rapalogs for treating hepatocellular carcinoma.
Watari K; Nishitani A; Shibata T; Noda M; Kawahara A; Akiba J; Murakami Y; Yano H; Kuwano M; Ono M
Oncotarget; 2016 Jul; 7(30):47403-47417. PubMed ID: 27329724
[TBL] [Abstract][Full Text] [Related]
23. DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma.
Chen J; Zhu H; Liu Q; Ning D; Zhang Z; Zhang L; Mo J; Du P; Liu X; Song S; Fan Y; Liang H; Liu J; Zhang B; Chen X
J Exp Clin Cancer Res; 2019 Jun; 38(1):273. PubMed ID: 31228948
[TBL] [Abstract][Full Text] [Related]
24. Hippocalcin-Like 1 blunts liver lipid metabolism to suppress tumorigenesis via directly targeting RUVBL1-mTOR signaling.
Chen T; Yuan Z; Lei Z; Duan J; Xue J; Lu T; Yan G; Zhang L; Liu Y; Li Q; Zhang Y
Theranostics; 2022; 12(17):7450-7464. PubMed ID: 36438486
[No Abstract] [Full Text] [Related]
25. Influence of Rictor and Raptor Expression of mTOR Signaling on Long-Term Outcomes of Patients with Hepatocellular Carcinoma.
Kaibori M; Shikata N; Sakaguchi T; Ishizaki M; Matsui K; Iida H; Tanaka Y; Miki H; Nakatake R; Okumura T; Tokuhara K; Inoue K; Wada J; Oda M; Nishizawa M; Kon M
Dig Dis Sci; 2015 Apr; 60(4):919-28. PubMed ID: 25371154
[TBL] [Abstract][Full Text] [Related]
26. Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.
Lin XM; Hu L; Gu J; Wang RY; Li L; Tang J; Zhang BH; Yan XZ; Zhu YJ; Hu CL; Zhou WP; Li S; Liu JF; Gonzalez FJ; Wu MC; Wang HY; Chen L
Gastroenterology; 2017 Apr; 152(5):1187-1202. PubMed ID: 28065789
[TBL] [Abstract][Full Text] [Related]
27. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
Xu L; Yang C; Wang J; Li Z; Huang R; Ma H; Ma J; Wang Q; Xiong X
Biochem Biophys Res Commun; 2021 Nov; 578():142-149. PubMed ID: 34562654
[TBL] [Abstract][Full Text] [Related]
28. circACTG1 Promotes Hepatocellular Carcinoma Progression by Regulating miR-940/RIF1 Axis and Activating AKT/mTOR Pathway.
Wu C; Tian S; Guo Y; Yu C; Lei L; Zheng D; Xie H; Zheng J; Sun C
J Immunol Res; 2022; 2022():8649386. PubMed ID: 35769514
[TBL] [Abstract][Full Text] [Related]
29. Branched chain amino acid suppresses hepatocellular cancer stem cells through the activation of mammalian target of rapamycin.
Nishitani S; Horie M; Ishizaki S; Yano H
PLoS One; 2013; 8(11):e82346. PubMed ID: 24312415
[TBL] [Abstract][Full Text] [Related]
30. CC-223 blocks mTORC1/C2 activation and inhibits human hepatocellular carcinoma cells in vitro and in vivo.
Xie Z; Wang J; Liu M; Chen D; Qiu C; Sun K
PLoS One; 2017; 12(3):e0173252. PubMed ID: 28334043
[TBL] [Abstract][Full Text] [Related]
31. KIFC3 regulates progression of hepatocellular carcinoma via EMT and the AKT/mTOR pathway.
Lu S; Liu Y; Tian S; He Y; Dong W
Exp Cell Res; 2023 May; 426(1):113564. PubMed ID: 36948354
[TBL] [Abstract][Full Text] [Related]
32. Reciprocal REGγ-mTORC1 regulation promotes glycolytic metabolism in hepatocellular carcinoma.
Yao L; Xuan Y; Zhang H; Yang B; Ma X; Wang T; Meng T; Sun W; Wei H; Ma X; Moses R; Xiao J; Zhang P; Ge C; Li J; Li L; Li X; Li J; Zhang B
Oncogene; 2021 Jan; 40(3):677-692. PubMed ID: 33230243
[TBL] [Abstract][Full Text] [Related]
33. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
[TBL] [Abstract][Full Text] [Related]
34. Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway.
Wang F; Xu WQ; Zhang WQ; Xu RC; Sun JL; Zhang GC; Liu ZY; Qi ZR; Dong L; Weng SQ; Shen XZ; Liu TT; Fang Y; Zhu JM
Hepatol Int; 2024 Apr; 18(2):636-650. PubMed ID: 37982952
[TBL] [Abstract][Full Text] [Related]
35. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.
Calvisi DF; Wang C; Ho C; Ladu S; Lee SA; Mattu S; Destefanis G; Delogu S; Zimmermann A; Ericsson J; Brozzetti S; Staniscia T; Chen X; Dombrowski F; Evert M
Gastroenterology; 2011 Mar; 140(3):1071-83. PubMed ID: 21147110
[TBL] [Abstract][Full Text] [Related]
36. MiR-92a-3p Promotes the Malignant Progression of Hepatocellular Carcinoma by Mediating the PI3K/AKT/mTOR Signaling Pathway.
Wang L; Cui M; Qu F; Cheng D; Yu J; Tang Z; Cheng L; Wei Y; Wu X; Liu X
Curr Pharm Des; 2021; 27(29):3244-3250. PubMed ID: 34126886
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of KIF18B facilitates malignant phenotype of esophageal squamous cell carcinoma by activating CDCA8/mTORC1 pathway.
Xie J; Wang B; Luo W; Li C; Jia X
J Clin Lab Anal; 2022 Oct; 36(10):e24633. PubMed ID: 36085568
[TBL] [Abstract][Full Text] [Related]
38. LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma.
Song XZ; Ren XN; Xu XJ; Ruan XX; Wang YL; Yao TT
Technol Cancer Res Treat; 2020; 19():1533033820957023. PubMed ID: 32910747
[TBL] [Abstract][Full Text] [Related]
39. Thioredoxin facilitates hepatocellular carcinoma stemness and metastasis by increasing BACH1 stability to activate the AKT/mTOR pathway.
Wang C; Zhang L; Cao M; Fu Z; Wang H; Zhang S; Zhu K; Hou Z; Cui J; Yue P; Guo H; Zhang T
FASEB J; 2023 Jun; 37(6):e22943. PubMed ID: 37104068
[TBL] [Abstract][Full Text] [Related]
40. Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling.
Li M; Jin C; Xu M; Zhou L; Li D; Yin Y
Cell Commun Signal; 2017 Dec; 15(1):52. PubMed ID: 29246230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
